Senate HELP To Hear From Stakeholders In Changed Cosmetics Industry
This article was originally published in The Rose Sheet
Since 2012 when a House committee held the last cosmetics hearing, industry generally has warmed to – or resigned itself to – legislative proposals to update the cosmetics regulatory system. However, there is still not consensus on the details among big business, SMEs and consumer advocates, all of which will be represented at the Senate HELP Committee’s witness table.
You may also be interested in...
In a letter to California Democratic Senator Dianne Feinstein, FDA’s Acting Associate Commissioner for Legislation Dayle Cristinzio acknowledges the agency’s limited insight into cosmetic formulations and safety information, which makes it a struggle to respond to issues as they arise. Feinstein characterizes the letter as an admission of current system failings and a nod of support for her Personal Care Products Safety Act.
Trade association for micro-sized cosmetics businesses says draft reform bills in the House and Senate propose exemption thresholds for registration and other requirements that are too low, failing to account for the high costs and unique challenges faced by its members.
The New Jersey congressmen are still working on language regarding a key challenge facing cosmetics legislation. There is still no consensus among stakeholders on whether and to what extent states should be barred from imposing regulations on cosmetic companies that differ from or add to federal requirements.